We are dedicated to industry-standard knowledge and quality
Helping You Globalize the Right Way
CSOFT’s experienced and dedicated global regulatory submission specialists help companies comply with these demanding multilingual documentation requirements for submissions while providing the highest linguistic quality
We can help you attain the appropriate, accurate, and sustainable compliance required throughout the entire submission process. We ensure our clients receive the necessary certifications to successfully enter emerging markets.
Medical Translation with a Focus on Precision
Our translation solutions are intended for document types relating to every stage of product development life cycle.
Quality in translation is extremely important, but within the life sciences industry, incorrect translations could literally be life threatening. We use industry-standard processes, however, we also offer flexibility for each customer to allow for their companies’ success, no matter the process.
Industries We Serve
Who We Are
CSOFT Health Sciences provides end-to-end medical translations for all phases of the product lifecycle, from pre-clinical to post-launch. We also specialize in market access consulting, medical writing, and CTD/eCTD submissions with the FDA, EMA, and NMPA.
Our operations are compliant with ISO 17100 and certified in ISO 9001:2015 and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of global submissions.
The Power of Linguistic Expertise
Right Tools. Right Resources
Tools we use
CAT Tools: Trados, MemoQ, Transifex, Smartling, WordServer
We translate all document types (.ai, .doc, .pdf, .ppt, .xlx, .css, .php, .html, .xml, .mml, .txt, .mpg, .mov, .zip, .psd, and more)
Linguists we hire
Our native in-country subject-matter experts with at least 7 years’ experience go through a rigorous certification process and are guided with customer experience surveys
Methodologies we employ
Customized solutions
Translation Memory
Style Guides & Glossary
PLLP
CSOFT works extensively with medical professionals who are dedicated to prevalent therapeutic areas
- Cardiology
- Dental
- Dermatology
- Gastroenterology
- Genetic Disease
- Hematology
- Hepatology
- Immunology
- Infections
- Neurology
- Oncology
- Orthopedics
- Pediatrics
- Psychology
- Rare Diseases
- Women’s Health
Start Your Global Journey
Headquarters
501 Boylston Street, 10th Floor
Boston, MA 02116
Phone
+1-617-263-8950 (US/Europe)
+86-10-5736-6000 (Asia)
The Knowledge Vault
Stay in the know
CSOFT life science blog aims to provide a better understanding of complex diseases, and regulatory policies from conducting experiments to introducing new type of drugs into the market.
United States Sets One-Day Record: Over 65,500 New Confirmed Cases of COVID-19
The United States on Thursday (7/10) reported across states, according to a Reuter’s tally, more than 60,500 new cases of COVID-19, setting the new record for the number of those confirmed to be infected in one day. As the cases are steadily on the rise in 41 out of...
Interviewing Dr. Nimita Limaye on the Challenges and Opportunities of Medical Communications in India
We’re here this week with Dr. Nimita Limaye, a distinguished leader in the international medical writing community and a recent addition to CSOFT Health Sciences’ growing team in Boston, Massachusetts, in the role of Senior Vice President, Strategic Partnerships &...
COVID-19 Potential for Brain Damage, According to Scientists
A study conducted by researchers at University College London (UCL) reported 43 cases of patients diagnosed with COVID-19 experiencing temporary brain damage. The scientists warned that new evidence suggests potential issues of severe neurological complications, like...
Over 200 Scientists Claim COVID-19 Is Airborne According to NYT
239 scientists from 32 countries have submitted an open letter with mounting evidence to the WHO that the COVID-19 virus can be spread through the air. The WHO has stated that only after medical procedures that produce aerosols, or droplets smaller than 5 microns is...
A Quicker Transition to Digitalizing Healthcare in the European Union
European Union Nations agree to accelerate their digital transformation as an ‘essential component of the EU’s response to the economic crisis generated by the COVID-19 pandemic.’ The impact of the COVID-19on the European Union’s diverse healthcare systems has ledEU...
Early Potential in Human Trials for COVID-19 Vaccine
BioNTech, a German based biotech company, and Pfizer, the well-established pharmaceutical company headquartered in the United States, have partnered to produce one of the 17 COVID-19 vaccines currently in development. The vaccine has shown promising early-stage human...
